TOKYO, March 19 (Reuters) - Takeda Pharmaceutical Co, Japan’s biggest drug maker, plans to spend some $5 billion to buy out Abbott Laboratories Inc in their 50-50 U.S. venture, a source briefed on the matter said on Wednesday.
TOKYO, March 19 (Reuters) - Takeda Pharmaceutical Co, Japan’s biggest drug maker, plans to spend some $5 billion to buy out Abbott Laboratories Inc in their 50-50 U.S. venture, a source briefed on the matter said on Wednesday.
